Trial Profile
A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavir boosted Darunavir in Therapy-naive HIV-1 Infected Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Rilpivirine (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 30 Nov 2017 Results published in the HIV Clinical Trials
- 14 Jun 2017 Status changed from recruiting to completed.
- 23 Dec 2012 New trial record